Kal Fishman – President & Chief Executive Officer
Mr. Fishman is a serial entrepreneur in the fields of radiation oncology and radiology. Mr. Fishman is the inventor of the robotically-assisted Morpheus™ beam sculpting image-guided radiotherapy system, which was taken from concept to FDA submission and clearance in approximately eighteen months and is Empyrean’s first commercial product. Before founding and launching Empyrean Medical Systems, Mr. Fishman was the co-founder and served as the Chief Technology Officer and Chief Operations Officer of Sensus Healthcare, Inc., a publicly traded company (Nasdaq®: SRTS) specializing in superficial, brachytherapy, and intraoperative oncological radiation therapy systems from 2010 to 2019. In addition, he held executive positions at other medical device companies, including GE Healthcare, Siemens Medical Systems, CTI, Elscint, Positron Medical Systems, and Rcadia Medical Imaging. He is a GE-certified Six-Sigma DFSS/DMAIC Black Belt. Before that, Mr. Fishman was a senior research and development engineer in the Israeli Air Force R&D Core at the Airborne Intelligence and Cryptography Division. Mr. Fishman holds over ten patents in radiation oncology, radiology, and bioinformatics. He also serves as the Chairman of the Board of Directors.